News and Press Releases
Radiation-Induced Lung Injury (RILI)
-
Aqualung Therapeutic's ALT-100 Monoclonal Antibody Cited as A Novel Therapeutic for Lung Fibrosis
April 2022
-
Tucson startup looks to human trials for drug to treat lung inflammation
Jan 2022
-
Aqualung Therapeutics Corp., an Immunotherapeutics Biotech Company, Closes a $2.5M Convertible Note Raise With a Committed Series A Lead Investor
Jan 2022
-
CEO & Founder of Aqualung Therapeutics Corp., Joe G.N. Garcia MD to Present Corporate Update at the Annual Biotech Showcase
Dec 2021
-
Aqualung Therapeutics Selected to Present at the Phoenix 2021 Venture Madness Competition
August 2021
-
Healing lungs, improving data, oncology research and more
June 2020
-
Aqualung Therapeutics Corporation Receives A $2.3 Million National Institute Of Health (NIH) Award To Develop A Novel Therapeutic Antibody For Patients With Radiation-Induced Lung Injury
June 2020
-
Radiation-induced lung injury: Is there finally an approved treatment on the way?
June 2020